Skip to main content
. 2020 Jan 23;9(2):328. doi: 10.3390/jcm9020328

Table 2.

Reasons for the conversion to everolimus.

Fast Metabolizers (n = 17) Slow Metabolizers (n = 17) p-Value
CNI-nephrotoxicity 13 (77%) 10 (59%) 0.277
chronic rejection 0 2 (12%)
DGF 1 (6%) 2 (12%)
NODAT 2 (12%) 0
BKV-infection 0 1 (6%)
neutropenia 0 1 (6%)
neurotoxicity 0 1 (6%)
study 1 (6%) 0

CNI, calcineurin inhibitor; DGF, delayed graft function; NODAT, new onset diabetes mellitus after transplantation; BKV, BK virus. Statistics: Fisher’s exact test.